News and Announcements
Texus Fibre Eyes $2.9b Face Mask Market in Asia
- Published January 11, 2017 4:22PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
22nd December 2016, Stuff NZ
A Kiwi company has secured a deal it hopes will unlock a lucrative $2.9 billion Asian healthcare market.
Texus Fibre uses natural wool to develop ‘functional materials’ – meaning they do something clever scientifically.
On Thursday it announced an investment and distribution deal with Auckland firm Healthy Breath Limited (HBL) for Texus’ wool-based air filter to be used in face masks marketed to city-dwellers in Asia.
Helix Filters harness and enhance wool’s natural toxin remove properties to stay drier and work for longer, Texus ceo Nick Davenport said, making it easier for people to breath in the masks and making them more effective at blocking out pollution.
To view the full announcement, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
